Japan-headquartered Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, has announced the launch of a new hemostasis clip to help meet the needs of GI endoscopists.
The Retentia HemoClip provides 360° rotation and an intuitive one-step deployment, offering control over placement with three different sizes to accommodate a variety of closure applications. It will launch in the US with plans for further global expansion.
Performing hemostasis within the GI tract is a technically demanding procedure and use of hemostatic clips and associated devices may result in patient injury including but not limited to inflammatory reaction, infection, bleeding and perforation.
The Retentia HemoClip is part of a comprehensive Olympus EndoTherapy portfolio that provides physicians with advanced solutions for procedures such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD).
EMR and ESD are techniques for removing cancerous or other abnormal tissues from the digestive tract. Olympus' endoscopic portfolio includes devices such as electrosurgical knives, and hemostatic forceps that provide targeted monopolar coagulation. The portfolio also includes technology to help detect and control gastrointestinal bleeding in combination with conventional techniques such as clips.
